Chapter References

1. Bleck TP: Tetanus: Pharmacology, management, and prophylaxis. Dis Mon 37:551, 1991.

2. Izurieta HS, Sutter RW, Strebel PM, et al: Tetanus surveillance: United States, 1991-1994. MMWR 46(SS-2):15, 1997.

3. Sutter RW, Cochi SL, Brink EW, et al: Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States 1979-1984. Am J Epidemiol 131:132, 1990.

4. Bardenheier B, Prevots DR, Khetsurian N, et al: Tetanus: Surveillance—United States, 1995-1997. MMWR 47(SS-2):1, 1998.

5. Kefer MP: Tetanus. Am J Emerg Med 10:445, 1992.

6. Mellanby J, Green J: How does tetanus toxin act? Neuroscience 6:281, 1981.

7. Gergen PJ, McQuillan GM, Kiely M, et al: A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 332:761, 1995.

8. Richardson JP, Knight AL: Prevention of tetanus in the elderly. Arch Intern Med 151:1712, 1991.

9. Ernst ME, Klepser ME, Fouts M, et al: Tetanus: Pathophysiology and management. Ann Pharmacother 31:1507, 1997.

10. Wright DK, Lalloo UG, Nayiager S, et al: Autonomic nervous system dysfunction in severe tetanus: Current perspectives. Crit Care Med 17:371, 1989.

11. Alfrey DD, Rauscher LA: Tetanus: A review. Crit Care Med 7:176, 1979.

12. Blake PA, Feldman TM, Buchanan TM, et al: Serologic therapy of tetanus in the United States, 1965-1971. JAMA 235:42, 1976.

13. Ahmadsyah I, Salim A: Treatment of tetanus: An open study to compare the efficacy of procaine penicillin and metronidazole. BMJ 291:648, 1985.

14. Muller H, Borner U, Zierski J, et al: Intrathecal baclofen for treatment of tetanus-induced spasticity. Anesthesiology 66:76, 1987.

15. Farquhar I, Hutchinson A, Curan J: Dantrolene in severe tetanus. Intensive Care Mea 14:249, 1988.

16. Powles AB, Ganta R: Use of vecuronium in the management of tetanus. Anaesthesia 40:879, 1985.

17. Buchanan N, Smit L, Cane RD, De Andrade M: Sympathetic overactivity in tetanus: Fatality associated with propranolol. BMJ 2:254, 1978.

18. Edmundson RS, Flowers MS: Intensive care in tetanus: Management, complications, and mortality in 100 cases. BMJ 1:401, 1979.

19. James MFM, Manson EDM: The use of magnesium sulfate infusions in the management of very severe tetanus. Intensive Care Med 11:5, 1985.

20. Southorn PA, Blaise GA: Treatment of tetanus-induced autonomic nervous system dysfunction with continuous epidural blockade. Crit Care Med 14:251, 1986.

21. Sutton DN, Tremlett MR, Woodcock TE, et al: Management of autonomic dysfunction in severe tetanus: The use of magnesium sulfate and clonidine. Intensive Care Med 16:75, 1990.

22. Dolar D: The use of continuous atropine infusion in the management of severe tetanus. Intensive Care Med 18:26, 1992.

23. American College of Emergency Physicians, Scientific Review Committee: Tetanus immunization recommendations for persons seven years of age and older. Ann Emerg Med 15:1111, 1986.

24. American College of Emergency Physicians, Scientific Review Committee: Tetanus immunization recommendations for persons less than seven years old. Ann Emerg Med 16:1181, 1987.

25. Recommendations of the Immunization Practices Advisory Committee (ACIP): Diphtheria, tetanus, and pertussis: Recommendations for vaccine use and other preventive measures. MMWR 40, RR-10, 1-28, 1991.

Peripheral Neuropathy Natural Treatment Options

Peripheral Neuropathy Natural Treatment Options

This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.

Get My Free Ebook

Post a comment